11:16 AM EST - Cangene Corporation : today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, in connection with Emergent BioSolutions Inc.'s proposed acquisition of Cangene, has expired. The expiration of the waiting period for antitrust review of the proposed acquisition satisfies one of the conditions to the closing of the acquisition. Cangene Corporation
shares T.CNJ are trading up $0.05 at $3.58.
